Actio Biosciences involves in the development of precision medicines for homogenous rare patient populations. They develop a pipeline of new medicines with the goal to enhance the probability of clinical success and deliver medicines for all patients.

Actio Biosciences

David Goldstein

We’re leveraging advances in genetics and precision medicine to develop new therapeutics that target shared, underlying biology in rare and common diseases — bringing meaningful medicines from one to many. With expertise in genetics, drug discovery and data sciences, we seek to identify programs where both biological and technical risk can be minimized to streamline the drug development process and bring forward exceptionally potent and precisely targeted therapeutics for patients.

Bioinformatics Organizations

Software Companies

Canaan Partners

EcoR1 Capital

Deerfield Management

Droia Ventures

Specialist investor for drug development companies

Euclidean Capital

Investment firm for individual & family services

San Diego

City in San Diego County, California, United States; second-largest city in California

United States of America

Country primarily located in North America

California

San Diego County

Custom Computer Programming Services

Computer Systems Design and Related Services

Professional, Scientific, and Technical Services

Software Publishers

Publishing Industries

Information

Publishing Industries (except Internet)

Computer Programming Services

Computer Programming, Data Processing, And Other Computer Related

Business Services

Prepackaged Software

Google Hosted Libraries

Google Font API

Google Remarketing Tag

core-js

webflow

Google Analytics

jQuery

ReCAPTCHA

Google Tag Manager

Actio Biosciences

Company Details

Founded

Employees

Raised

Headquarters Location

Public

Acquired

CEO

Company Collections

Actio Biosciences' Industries

💸 Investors

📚 Popular Blog Posts